EE338 NICE Reconsideration for Oncology Drugs Based on Single-Arm Trials Referred to Cancer Drug Fund

Abstract

Authors

S Wu D Zou E Zhang

Full Text Cite This Article
Back to Volume 27, Supplemental Issue 6S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×